Candel Therapeutics, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Candel Therapeutics, Inc. (CADL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Candel Therapeutics, Inc. has filed 14 10-Q documents with the SEC since 2021. To view all SEC filings by Candel Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-279086 | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-108450 | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-069833 | May 13, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-126767 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-095784 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-059118 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-061566 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-040984 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-020873 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-024197 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-014970 | Aug 5, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009479 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004274 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-047259 | Sep 8, 2021 | Jun 30, 2021 |